Will I be able to move my injured body part after stem cell therapy?
Many people with sports and musculoskeletal injuries regain mobility over time, and stem cell therapy can support that process, although no treatment can guarantee full recovery of movement.

Whether movement improves depends on the type and severity of the injury, which tissue is damaged, how long ago it happened, your age and health, and above all on structured rehabilitation. In clinical research, mesenchymal stem cells (MSCs) applied to joints and tendons have shown improvements in pain and function, particularly in knee osteoarthritis, with results that vary by injury. At Stem Cell Mexico, athlete protocols use only allogeneic MSCs from Wharton's jelly of the umbilical cord, applied locally with ultrasound guidance, and they are designed to support, not replace, physical therapy and orthopedic care. The goal is to help you recover function, but the outcome cannot be promised.
This guide explains what determines mobility after an injury, what cell therapy may and may not contribute, and how to set realistic goals for returning to movement and sport.
What limits movement after an injury
Movement depends on several structures working together: bones, cartilage, ligaments, tendons, muscles, nerves and the joint capsule. Mobility can be limited by:
- Pain, which causes the body to protect the area and avoid movement.
- Swelling and inflammation, which reduce range of motion.
- Structural damage, such as a torn ligament or tendon, a cartilage defect or a fracture.
- Stiffness and scar tissue, often after prolonged immobilization or surgery.
- Muscle weakness and loss of coordination, which develop quickly when a limb is not used.
- Nerve injury, which can affect strength and sensation.
- Fear of movement, which is common after painful injuries and can slow recovery.
Each of these has a different solution. A treatment that reduces pain and inflammation may help movement, but it cannot reconnect a fully ruptured tendon or replace a missing ligament.
What MSCs may contribute
MSCs from Wharton's jelly work mostly through paracrine signaling: they release factors that may reduce inflammation, modulate the immune response and support the repair activity of the body's own cells. In musculoskeletal research, this has been studied for:
- Knee osteoarthritis: a 2024 systematic review and meta-analysis of randomized controlled trials found that MSC injections were associated with improvements in pain and function compared with controls in several studies, while noting variability in cell products, doses and study quality.
- Tendon injuries: studies in conditions such as tennis elbow, rotator cuff tendinopathy and Achilles tendinopathy report improvements in some patients.
- Cartilage and ligament healing: research is ongoing, often in combination with surgical repair.
MSCs are not expected to regrow large structures such as a fully torn anterior cruciate ligament (ACL) or a complete tendon rupture. These injuries often require surgical repair, and cell therapy, if considered, is investigated as an adjunct to surgery rather than a replacement.
What expert consensus says
The 2020 NBA Orthobiologics Consensus Statement, written by sports medicine experts who care for professional athletes, recognized growing interest in cell-based treatments and noted that products vary widely. It recommended careful patient selection, documentation of the product used and continued research.
Which injuries tend to respond better
Based on current research, the following situations are more often studied and may be more suitable for regenerative approaches:
- Mild to moderate knee osteoarthritis with pain and stiffness.
- Chronic tendinopathies that have not improved with a well-designed rehabilitation program.
- Partial tears of tendons or ligaments, in selected cases and with medical imaging.
- Persistent joint pain after an injury, when structural damage does not require surgery.
Situations where cell therapy is unlikely to restore movement on its own include complete ruptures, unstable joints, displaced fractures, severe joint deformity, nerve injuries with loss of function and advanced bone-on-bone arthritis.
Rehabilitation is the main driver of mobility
Regardless of any injection, restoring movement requires active work. A physical therapist designs a progressive program that typically includes:
- Protection and pain control in the early phase.
- Range-of-motion exercises to restore flexibility and prevent stiffness.
- Strengthening of the injured area and the muscles that support it.
- Neuromuscular and balance training to restore coordination and prevent reinjury.
- Sport-specific training and gradual return to competition.
When MSCs are used, the rehabilitation program is adapted to allow the treated tissue to recover. Many athletes report that reduced pain allows them to participate more fully in therapy, which is part of how improvement may occur. Skipping rehabilitation reduces the chances of recovering movement, with or without cell therapy.
How treatment is done at Stem Cell Mexico
- Cells: allogeneic MSCs from Wharton's jelly of donated umbilical cords, obtained after healthy, full-term births with informed consent and donor screening. No autologous cells or other cell sources are used.
- Laboratory: produced in a COFEPRIS-licensed laboratory under Good Manufacturing Practice standards, with quality and safety testing before release.
- Evaluation: review of your MRI, X-rays or ultrasound, orthopedic notes and rehabilitation history.
- Application: local injection into the affected joint, tendon or ligament with ultrasound guidance, sometimes combined with an IV infusion when the medical team considers it appropriate.
- Follow-up: a structured return-to-activity plan and follow-up with standardized measures of pain, range of motion and function.
Safety
In clinical research, local MSC injections into joints and soft tissues have a generally favorable safety profile. The most common effects are temporary pain, swelling and stiffness at the injection site for a few days. Infection is rare but possible, which is why sterile technique and image guidance are important. No treatment is free of risk, and overloading the treated area too early can lead to setbacks.
Anti-doping considerations
If you are a drug-tested athlete, the World Anti-Doping Agency (WADA) Prohibited List includes a category for gene and cell doping (M3), which lists "the use of normal or genetically modified cells" among prohibited methods. Consult your team physician and your federation or anti-doping organization before treatment. We can provide documentation describing the product and procedure.
How progress is measured
Because pain and movement can change from day to day, progress should be measured with objective tools before and after treatment:
- Range of motion, measured in degrees with a goniometer by your physical therapist.
- Strength, compared with the uninjured side using manual testing or dynamometry.
- Validated questionnaires, such as the KOOS for the knee or similar scores for the shoulder, elbow and ankle.
- Functional tests, including single-leg hop tests, balance tests and sport-specific drills.
- Imaging, when your doctor considers it useful to assess tissue changes.
Comparing these measures over three, six and twelve months gives a clearer picture than impressions alone and helps your team decide when it is safe to increase training load.
Warning signs when comparing clinics
Be cautious if a clinic:
- Promises full recovery of movement or a guaranteed return to sport.
- Suggests you can skip rehabilitation or surgery that has been recommended.
- Says the treatment is risk-free.
- Does not review your imaging before recommending treatment.
- Cannot explain the cell source, dose and laboratory testing.
Realistic expectations
- Improvement, when it occurs, is usually gradual, over weeks to months.
- Pain relief may come before measurable gains in strength or range of motion.
- Some patients experience significant improvement and others more modest change.
- Returning to sport depends on objective criteria such as strength, stability and sport-specific tests, not only on how the area feels.
- Older injuries with long-standing stiffness or muscle loss usually need a longer rehabilitation period, regardless of any injection.
Who may be a candidate
- Athletes and active adults with joint, tendon or ligament injuries confirmed by imaging.
- Injuries that do not require urgent surgery, or patients who have discussed surgical options with an orthopedic specialist.
- No active infection or cancer within the past five years.
- Commitment to a structured rehabilitation program.
What our patients usually receive
Based on the treatment plans our team prepares for patients, a typical protocol at Stem Cell Mexico includes:
- 20 to 40 million Wharton's jelly MSCs per treated area, applied by direct injection with ultrasound guidance, or fluoroscopy guidance for the spine.
- Platelet-rich plasma (PRP) in many plans, applied together with the cells.
- One night at our facilities with nursing and medical monitoring.
- Consultation with your doctor and the stem cell specialist, pre-treatment laboratory tests and ground transportation from the San Diego airport area.
- Your recent imaging: an MRI of the area no older than three months is requested; if yours is older, a new one can be scheduled in Tijuana on your arrival day.
Based on what patients tell us, many begin to notice improvement within a few days to a few weeks after the application, while others improve more gradually over the following months. Our team stays in contact after treatment to follow your progress and decide whether a second application or a PRP session could help.
Questions to ask during your evaluation
- Which structure is injured, and can it heal without surgery?
- What improvement in movement is realistic in my case?
- How will my rehabilitation be adjusted after treatment?
- When can I return to training and competition, and what criteria will be used?
- Are there anti-doping considerations for my sport?
Bottom line
Stem cell therapy may help reduce pain and support healing in some sports injuries, which can make recovering movement easier, but it cannot guarantee that an injured body part will move normally again. Results depend on the injury, the tissue involved and, above all, on rehabilitation. At Stem Cell Mexico, Wharton's jelly MSCs are used as part of a comprehensive plan, not as a stand-alone solution. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your injury, goals and medical history.
References
- Cole BJ et al. The 2020 NBA Orthobiologics Consensus Statement. Orthopaedic Journal of Sports Medicine, 2021 (opens in a new tab)
- Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
- International Society for Stem Cell Research (ISSCR): The ISSCR Guide to Stem Cell Treatments (opens in a new tab)
- World Anti-Doping Agency (WADA): The Prohibited List (opens in a new tab)
